ReviewChemistry, an Asian journal2025
From Inception to Innovation: 20 Years of Nanoarchitectonics.
Review in Chemistry, an Asian journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Rational Design of Water-Soluble Dipyrroethene-Based Red-Light Emissive Chromophores for Rapid and Selective Recognition of Serum Albumins.Chembiochem : a European journal of chemical biology · 2026Article
- Nanoarchitectonics of molecular machines, biomolecular machines, and microrobots in their collective behaviour.Chemical science · 2026Review
- Amphiphilic Baskets for Supramolecular Nanoarchitectures at Interfaces: Inverted Monolayer Formation on Water.Langmuir : the ACS journal of surfaces and colloids · 2026Article
- Introduction to carbon nanoarchitectonics for advanced applications in energy, environment and bio.Nanoscale advances · 2026Article
- Vision of Life's Code: Molecular Probe Nanoarchitectonics for Deep RNA/DNA Illumination.ACS nano · 2026Review
- Nanoarchitectonics in Materials Science, Second Edition.Materials (Basel, Switzerland) · 2026Article
- Foreword to the focus issue, 'nanoarchitectonics reloaded: method for everything in materials science'.Science and technology of advanced materials · 2026Article
- Fascinating Frontier, Nanoarchitectonics, as Method for Everything in Materials Science.Materials (Basel, Switzerland) · 2025Review
- From Inception to Innovation: 20 Years of Nanoarchitectonics.Chemistry, an Asian journal · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The term "nanoarchitectonics" emerged as the 21st century approached, and it has been in use for around 20 years. We here look back accomplishments of nanoarchitectonics. However, this review will explore several typical topics and their trends instead of a comprehensive description in a chronicle-like manner. Atomic switches and local probe chemistry handle basic-level nanoarchitectonics involving atomic/molecular manipulations. Even within these typical approaches to nanoarchitectonics, the latest research focuses on artificial intelligence. Innovation is also coming to fundamental nanoarchitectonics. Nanoarchitectonics of two-dimensional (2D) and layered materials are characterized by their potential for various practical applications. This lends nanoarchitectonics a sense of innovation with a view to practical applications. Nanoarchitectonics at liquid interfaces have broad applicability to a range of systems, from simple molecules to complex biological systems. The ability to control molecular structure through macroscopic movements that can be used for mass production paves the way for nanoarchitectonics to be applied in industry. The number of papers claiming to be in this field has increased significantly in recent years, as has the scope of its applications. Given these limitless advancements, one might say that nanoarchitectonics is a method for everything in materials science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.